CTRI/2023/06/054560Not yet recruitingPhase 3
SINGLE ARM CLINICAL STUDY TO EVALUAVTE THE ROLE OF MANJISHTHADI TAILA SHIROABHYAGA IN THE MANAGEMENT OF DARUNAKA - NI
SUPRIYA VIJAYRAO SALUNKHE0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1) Darunaka Patients having Signs and Symptoms of Kandu, twaksphutana, keshbhumi rukshta, keshachuti
- •2) Darunaka Patients between the age group 18 to 60 years.
- •3)Darunaka Patients who are willing for treatment.
- •4)Patients were not allowed to take any other medicine either orally or by other routes.
Exclusion Criteria
- •1)Patients below 18 and above 60 years age are excluded
- •2)Darunaka (Contraindicated) Patients.
- •3)Patients suffering from other systemic Disease.
- •4)Patient taking other modality of treatment for Darunaka
Investigators
Similar Trials
Not yet recruiting
Phase 2
Clinical study of Agnikarma by Pippali in MigraineCTRI/2023/03/050429Dr Juned Aslam Kothali
Not yet recruiting
Phase 2
STUDY HELD TO SEE THE EFFECT OF BALPANCHAMRUTA POWEDER (CHURNA) IN THE MANAGEMENT OF UNDERWEIGHT CHILDREN. (KARSHYA VYADHI).CTRI/2021/01/030516Dr Abhishek Maniklal Doshi
Not yet recruiting
Phase 2
STUDY HELD TO SEE THE EFFECT OF BHARANGYADI POWDER IN DRY COUGH IN CHILDRECTRI/2020/11/029423Dr Vaibhav Manikrao Patil
Recruiting
Phase 2
A STUDY HELD TO SEE THE EFFECT OF NIMBADI BIDALAKA IN THE MANAGEMENT OF KRIMIGRANTHI (BLEPHARITIS)CTRI/2023/03/050424Kirti Kailasrao Sengaonkar
Not yet recruiting
Phase 2
A STUDY OF PARSIYADI CHURNA (POWDER) IN TREATMENT OF KRIMI (WORM)CTRI/2021/11/037960DR YOGESH SUKDEV GADAKH